4DMedical Limited (ASX:4DX)

Australia flag Australia · Delayed Price · Currency is AUD
1.900
+0.060 (3.26%)
At close: Dec 5, 2025
248.62%
Market Cap 980.50M
Revenue (ttm) 5.85M
Net Income (ttm) -30.07M
Shares Out 516.05M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,327,651
Average Volume 2,699,131
Open 1.850
Previous Close 1.840
Day's Range 1.815 - 2.000
52-Week Range 0.225 - 2.550
Beta 2.61
RSI 60.94
Earnings Date Nov 27, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 124
Stock Exchange Australian Securities Exchange
Ticker Symbol 4DX
Full Company Profile

Financial Performance

In 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.

Financial Statements

News

There is no news available yet.